Open Label, Extension Study of PRO044 in Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT02329769 · TERMINATED
Trial details
- NCT number
- NCT02329769
- Sponsor
- BioMarin Pharmaceutical
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-07-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.